Nureca Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nureca Limited reported audited financial results for Q4 and FY26. Full-year revenue grew 28.4% to ₹1,472.10 million from ₹1,146.40 million in FY25. The company turned profitable with PAT of ₹2.97 million compared to a loss of ₹6.68 million in the previous year. However, Q4 standalone showed a significant loss of ₹66.25 million. The auditors issued an unmodified (clean) opinion. Key changes include CFO resignation and immediate replacement, new director appointment, and reappointment of key management. The board also approved ₹100 crore capex for manufacturing expansion and share buyback was completed at ₹330 per share. A material non-operating loss of ₹83.37 million on fair value changes was separately disclosed.
Revenue growth is strong at 28.4% YoY and the company returned to profitability. However, Q4 loss and pending CFO transition may create short-term concern. The clean audit opinion removes going concern worries. Management changes and expansion plans signal growth focus.